Cargando…
Expression of Shh, Gli1, and Cyr61 in Gastric Cancer Predicts Overall Survival of Patients: A Retrospective Study
OBJECTIVE: This study aimed to evaluate the expression levels of Shh, Gli1, and Cyr61 proteins in gastric cancer tissues and analyze the relationship between these three proteins and the clinicopathological factors and prognosis of patients. METHODS: This was a retrospective study. Four hundred gast...
Autores principales: | Quan, Xiaoling, Zhang, Zhenming, Qin, Yujie, Gai, Xin, Tian, Qiling, Guo, Yaqiong, Qian, Jun, Yao, Jiaxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647287/ https://www.ncbi.nlm.nih.gov/pubmed/36346167 http://dx.doi.org/10.1177/10732748221134398 |
Ejemplares similares
-
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
por: Wei, Jing, et al.
Publicado: (2016) -
The Roles of CCN1/CYR61 in Pulmonary Diseases
por: Zhu, Yin, et al.
Publicado: (2020) -
Aberrant activation of CYR61 enhancers in colorectal cancer development
por: Xie, Lingzhu, et al.
Publicado: (2019) -
Quercetin Suppresses CYR61-Mediated Multidrug Resistance in Human Gastric Adenocarcinoma AGS Cells
por: Hyun, Ho Bong, et al.
Publicado: (2018) -
GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
por: Srivastava, Ritesh K., et al.
Publicado: (2014)